Year To Quarter End Consolidated Statement Of Income

COSMO BIO COMPANY, LIMITED - Filing #7338716

Concept 2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
2,943,000,000 JPY
2,828,000,000 JPY
Cost of sales
1,956,000,000 JPY
1,789,000,000 JPY
Gross profit (loss)
987,000,000 JPY
1,039,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
681,000,000 JPY
638,000,000 JPY
Operating profit (loss)
305,000,000 JPY
400,000,000 JPY
Non-operating income
Interest income
2,000,000 JPY
1,000,000 JPY
Dividend income
4,000,000 JPY
3,000,000 JPY
Non-operating income
14,000,000 JPY
16,000,000 JPY
Non-operating expenses
Interest expenses
0 JPY
0 JPY
Non-operating expenses
20,000,000 JPY
0 JPY
Ordinary profit (loss)
299,000,000 JPY
416,000,000 JPY
Extraordinary income
Extraordinary income
53,000,000 JPY
JPY
Profit (loss) before income taxes
353,000,000 JPY
416,000,000 JPY
Income taxes
112,000,000 JPY
137,000,000 JPY
Profit (loss)
240,000,000 JPY
279,000,000 JPY
Profit attributable to
Profit (loss) attributable to non-controlling interests
10,000,000 JPY
15,000,000 JPY
Profit (loss) attributable to owners of parent
230,000,000 JPY
264,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
297,000,000 JPY
44,000,000 JPY
Deferred gains or losses on hedges
10,000,000 JPY
4,000,000 JPY
Foreign currency translation adjustment
13,000,000 JPY
1,000,000 JPY
Other comprehensive income
321,000,000 JPY
49,000,000 JPY
Comprehensive income
561,000,000 JPY
329,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
551,000,000 JPY
314,000,000 JPY
Comprehensive income attributable to non-controlling interests
10,000,000 JPY
15,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.